$72.65
+1.45 (+2.04%)
At Close: Jun 03, 2026
Corcept Therapeutics Incorporated (CORT) Q4 2019 Earnings Call Transcript
02:31am, Friday, 21'st Feb 2020
CORT earnings call for the period ending December 31, 2019.
Corcept Therapeutics, Inc. (CORT) CEO Joseph Belanoff on Q4 2019 Results - Earnings Call Transcript
01:42am, Friday, 21'st Feb 2020
Corcept Therapeutics, Inc. (NASDAQ:CORT) Q4 2019 Earnings Conference Call February 20, 2020, 17:00 ET Company Participants Gary Robb - CFO & Secretary Josep
Corcept Therapeutics (CORT) Meets Q4 Earnings Estimates
11:15pm, Thursday, 20'th Feb 2020
Corcept (CORT) delivered earnings and revenue surprises of 0.00% and -0.01%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Corcept Therapeutics (CORT) Meets Q4 Earnings Estimates
11:15pm, Thursday, 20'th Feb 2020
Corcept (CORT) delivered earnings and revenue surprises of 0.00% and -0.01%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Corcept: 4Q Earnings Snapshot
10:06pm, Thursday, 20'th Feb 2020
MENLO PARK, Calif. (AP) _ Corcept Therapeutics Inc. (CORT) on Thursday reported fourth-quarter profit of $29.4 million. On a per-share basis, the Menlo Park, California-based company said it had net i
Corcept: 4Q Earnings Snapshot
10:05pm, Thursday, 20'th Feb 2020
MENLO PARK, Calif. (AP) _ Corcept Therapeutics Inc. (CORT) on Thursday reported fourth-quarter profit of $29.4 million.
On a per-share basis, the Menlo Park, California-based company said it had net i
Corcept Therapeutics Q4 EPS $0.24 Misses $0.25 Estimate, Sales $87.9M Beat $87.67M Estimate
09:19pm, Thursday, 20'th Feb 2020Corcept Therapeutics Announces Fourth Quarter And Full-Year 2019 Audited Financial Results And Provides Corporate Update
09:05pm, Thursday, 20'th Feb 2020
MENLO PARK, Calif., Feb. 20, 2020 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat.
Sign In
Buy CORT